The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cost-Effectiveness of Pneumococcal Conjugate Vaccine: Evidence From the First 5 Years of Use in the United States Incorporating Herd Effects
Abstract
BACKGROUND: Pneumococcal conjugate vaccine (PCV) has been in routine use in the United States for 5 years. Prior U.S. cost-effectiveness analyses have not taken into account the effect of the vaccine on nonvaccinated persons. METHODS: We revised a previously published model to simulate the effects of PCV on children vaccinated between 2000 and 2004, and to incorporate the effect of the vaccine in reducing invasive pneumococcal disease (IPD) in nonvaccinated persons during those years. Data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention (2000-2004) were used to estimate changes in the burden of IPD in nonvaccinated adults since the introduction of PCV (compared with the baseline years 1997-1999). Results combined the simulated effects of the vaccine on the vaccinated and nonvaccinated populations. RESULTS: Before incorporating herd effects in the model, the PCV was estimated to have averted 38,000 cases of IPD during its first 5 years of use at a cost of dollar 112,000 per life-year saved. After incorporating the reductions in IPD for nonvaccinated individuals, the vaccine averted 109,000 cases of IPD at a cost of dollar 7500 per life-year saved. When the herd effect was assumed to be half that of the base case, the cost per life-year saved was dollar 18,000. CONCLUSIONS: IPD herd effects in the nonvaccinated population substantially reduce the cost, and substantially improve the cost-effectiveness, of PCV. The cost-effectiveness of PCV in actual use has been more favorable than predicted by estimates created before the vaccine was licensed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Cited by
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Pollard, A. J., Perrett, K. P., & Beverley, P. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2494 · Cited by 485
Zhou, F., Shefer, A., Kong, Y., & Nuorti, J. P. (2008) · Pediatrics · doi:10.1542/peds.2007-0619 · Cited by 273
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A., Wenger, J., Messonnier, M., Wang, L. Y., Lopez, A., Moore, M., Murphy, T. V., Cortese, M., & Rodewald, L. (2014) · Pediatrics · doi:10.1542/peds.2013-0698 · Cited by 259
Metadata
- Authors
- Ray, G. T., Whitney, C. G., Fireman, B. H., Ciuryla, V., & Black, S. B.
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2006-06
- Volume
- 25
- Issue
- 6
- Pages
- 494-501
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2056834435
- Cited by
- 162
- References
- 1
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness of Pneumococcal Conjugate Vaccine: Evidence From the First 5 Years of Use in the United States Incorporating Herd Effects. https://app.cochat.ai/papers/10.1097/01.inf.0000222403.42974.8b
- The paper
- Ray, G. T., Whitney, C. G., Fireman, B. H., Ciuryla, V., & Black, S. B. (2006). Cost-Effectiveness of Pneumococcal Conjugate Vaccine: Evidence From the First 5 Years of Use in the United States Incorporating Herd Effects. Pediatric Infectious Disease Journal. https://doi.org/10.1097/01.inf.0000222403.42974.8b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.